Lung Function Variations in AERD vs Aspirin-Tolerant Asthma
FEV1 increased in patients with aspirin-tolerant asthma while on standard asthma treatment but declined in patients with aspirin-exacerbated respiratory disease.
AAAAI 2020
Complete Coverage
LAMA Addition to Corticosteroid and LABA Combo Offers Improved Asthma Control
Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol provided greater increases in lung function compared to once-daily fluticasone furoate/vilanterol in patients with poorly controlled asthma.
Dupilumab Is an Effective Add-On Therapy for Aspirin-Exacerbated Respiratory Disease
Researchers evaluated the efficacy of dupilumab for chronic rhinosinusitis with nasal polyposis in aspirin-exacerbated respiratory disease.
Assessing Biologic Therapy in Asthma With/Without CRS in a Real-World Setting
In a real-world setting, biologic agents offered diverse clinical benefits in patients with asthma with and without chronic rhinosinusitis.
Hereditary Angioedema Monthly Attack Rates Decreased With Addition of Lanadelumab
Treatment with 300 mg lanadelumab every 2 weeks significantly reduced monthly hereditary angioedema attack rates compared with the 3-month historic baseline.
Poorer Sleep Quality Associated With Asthma Plus Atopic Dermatitis
Children with asthma and atopic dermatitis experience worse sleep and lung function outcomes compared with children with asthma alone.
Prenatal Exposure to Antacids Increases Food Protein-Induced Allergic Proctocolitis Risk
Prenatal exposure to calcium carbonate antacids was associated with the development of food protein-induced allergic proctocolitis, a type of delayed inflammatory gut food allergy to protein, in offspring.
Asthma Severity Worse for Women Despite Similar Response to Benralizumab
Although women are more likely than men to experience more severe asthma, they respond similarly to benralizumab therapy.
Antibiotic Exposure in Pregnancy Increases Risk for Childhood Atopic Dermatitis
Exposure to several antibiotics during pregnancy may be linked to the development of atopic dermatitis in offspring within the first 24 months of life.
Omalizumab Improves CRS With Nasal Polyps, Regardless of Asthma Status
In patients with chronic rhinosinusitis with nasal polyps, regardless of their asthma status, omalizumab was associated with improvements in nasal polyps score, nasal congestion score, and sinonasal outcome test score.
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in AAAAI 2020
